首页 » NPC43 NTCC®人鼻咽癌细胞株human nasopharyngeal carcinoma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

NPC43 NTCC®人鼻咽癌细胞株human nasopharyngeal carcinoma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

  • 价  格:¥49850
  • 货  号:NTCC®-NPC43
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

NPC43 NTCC®人鼻咽癌细胞株human nasopharyngeal carcinoma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心


NPC43 is a human nasopharyngeal carcinoma cell line that has been established from a biopsy specimen of a male patient. It is characterized by its persistent expression of Epstein-Barr virus (EBV), a common feature of nasopharyngeal carcinoma.

Key Features of NPC43:

  • EBV-Positive: Maintains high levels of EBV, a hallmark of nasopharyngeal carcinoma.

  • Adherent: Grows as adherent monolayers.

  • Origin: Derived from a 64-year-old male patient with nasopharyngeal carcinoma.

  • Genetic Alterations: Carries a TP53 mutation, a common genetic alteration in cancer.

Applications of NPC43:

  • Cancer Research: Studying the biology of nasopharyngeal carcinoma, including the role of EBV in tumorigenesis.

  • Drug Discovery: Screening for potential anti-cancer drugs.

  • Model Systems: Developing in vitro models to study the effects of different treatments on nasopharyngeal carcinoma cells.

  • EBV Research: Investigating the interactions between EBV and host cells in the context of cancer.


Image

Establishment of Nasopharyngeal Carcinoma Cell Lines, Patient-Derived  Xenografts, and Immortalized Nasopharyngeal Epithelial Cell Lines for  Nasopharyngeal Carcinoma and Epstein–Barr Virus Infection Studies -  ScienceDirect

生产厂家Supplier:

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

E-mail:BioVector@163.com


http://www.biovector.net


您正在向 biovector.net  发送关于产品 NPC43 NTCC®人鼻咽癌细胞株human nasopharyngeal carcinoma cell line-BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。